You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR LUBIPROSTONE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for LUBIPROSTONE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00380250 ↗ Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation Completed Takeda Phase 3 2005-05-01 The primary purpose of this study is to evaluate the efficacy and safety of administration of lubiprostone in patients with irritable bowel syndrome with constipation.
NCT00380250 ↗ Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation Completed Sucampo Pharma Americas, LLC Phase 3 2005-05-01 The primary purpose of this study is to evaluate the efficacy and safety of administration of lubiprostone in patients with irritable bowel syndrome with constipation.
NCT00380250 ↗ Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation Completed Sucampo Pharmaceuticals, Inc. Phase 3 2005-05-01 The primary purpose of this study is to evaluate the efficacy and safety of administration of lubiprostone in patients with irritable bowel syndrome with constipation.
NCT00399542 ↗ Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation Completed Sucampo Pharmaceuticals, Inc. Phase 3 2005-05-01 The primary purpose of this study is to evaluate the efficacy and safety of administration of lubiprostone in patients with irritable bowel syndrome with constipation.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for LUBIPROSTONE

Condition Name

Condition Name for LUBIPROSTONE
Intervention Trials
Constipation 14
Chronic Idiopathic Constipation 8
Irritable Bowel Syndrome 5
Opioid-Induced Bowel Dysfunction 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for LUBIPROSTONE
Intervention Trials
Constipation 31
Irritable Bowel Syndrome 8
Syndrome 5
Opioid-Induced Constipation 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for LUBIPROSTONE

Trials by Country

Trials by Country for LUBIPROSTONE
Location Trials
United States 359
Canada 12
United Kingdom 11
Mexico 8
Korea, Republic of 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for LUBIPROSTONE
Location Trials
Texas 17
Florida 14
California 14
Alabama 14
Arkansas 13
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for LUBIPROSTONE

Clinical Trial Phase

Clinical Trial Phase for LUBIPROSTONE
Clinical Trial Phase Trials
Phase 4 12
Phase 3 21
Phase 2/Phase 3 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for LUBIPROSTONE
Clinical Trial Phase Trials
Completed 39
Terminated 4
Recruiting 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for LUBIPROSTONE

Sponsor Name

Sponsor Name for LUBIPROSTONE
Sponsor Trials
Takeda 24
Sucampo Pharma Americas, LLC 18
Sucampo Pharmaceuticals, Inc. 15
[disabled in preview] 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for LUBIPROSTONE
Sponsor Trials
Industry 84
Other 30
NIH 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.